CP-609,754 in Treating Patients With Advanced Solid Tumors

NCT00006085 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: CP-609,754

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]